← Leaderboards
Richard C Ahrens
University Of Iowa
$204,951
Attributed
$204,951
Total exposure
24
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $61.5K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$204,951 · 24
By mechanism
M01$204,951 · 24
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- John F Engelhardt$56,184,900
- Alix Ashare$6,591,362
- Michael J. Welsh$31,109,771
- Paul B McCray$33,563,463
- Joseph Zabner$29,014,505
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisClinical ResearchHuman Therapy EvaluationHuman SubjectDrug Screening /EvaluationSourceRespiratory Disorder ChemotherapyComputer Retrieval Of Information On Scientific Projects DatabaseResourcesResearch PersonnelInstitutionUnited States National Institutes Of HealthGrantFundingInhalation Drug AdministrationDosageSafetyCystic Fibrosis PatientsRandomizedPlacebosDouble-Blind MethodClinical Trial Phase ILungOral Administration
Grant awards (31)
ULTRASE MT20 FOR CORRECTION OF STEATORRHEA IN PATIENTS WITH CYSTIC FIBROSIS$22,117
M01 · FY2007 · RR · contact PI
ERUAND PANCREATIC ENZYME PRODUCT (PEP) IN PATIENTS WITH CYSTIC FIBROSIS$11,534
M01 · FY2007 · RR · contact PI
EURAND PANCREATIC ENZYME PRODUCT MICROTABS IN PEDIATRIC CF PATIENTS$1,901
M01 · FY2007 · RR · contact PI
GENETIC MODIFIERS OF CYSTIC FIBROSIS: SIBLING STUDY$1,358
M01 · FY2007 · RR · contact PI
ANTIMICROBIAL THERAPY FOR NEW ONSET PSEUDOMONAS AERUGINOSA AIRWAY INFECTION$950
M01 · FY2007 · RR · contact PI
STANDARD VERSUS BIOFILM SUSCEPTIBILITY TESTING IN CYSTIC FIBROSIS$813
M01 · FY2007 · RR · contact PI
AZTREONAM LYSINATE IN CF PATIENTS WITH PULMONARY PNEUMONIA AERUGINOSA$680
M01 · FY2007 · RR · contact PI
TIOTROPIUM BROMIDE ADMINISTERED VIA THE RESPIMAT DEVICE IN CF PATIENTS$544
M01 · FY2007 · RR · contact PI
MULTICENTER INVESTIGATION OF GENETIC MODIFIER IN CF LUNG OR LIVER DISEASE STUDY$135
M01 · FY2007 · RR · contact PI
INDUCED SPUTUM TO EVALUATE ANTI-INFLAMMATORY AGENTS IN CF PATIENTS$13,897
M01 · FY2006 · RR · contact PI
STANDARD VERSUS BIOFILM SUSCEPTIBILITY TESTING IN CYSTIC FIBROSIS$4,963
M01 · FY2006 · RR · contact PI
ANTIMICROBIAL THERAPY FOR NEW ONSET PSEUDOMONAS AERUGINOSA AIRWAY INFECTION$2,978
M01 · FY2006 · RR · contact PI
MULTICENTER INVESTIGATION OF GENETIC MODIFIER IN CF LUNG OR LIVER DISEASE STUDY$1,655
M01 · FY2006 · RR · contact PI
ORAL THERACLEC-TOTAL IN CYSTIC FIBROSIS SUBJECTS$55,037
M01 · FY2005 · RR
STANDARD VERSUS BIOFILM SUSCEPTIBILITY TESTING IN CYSTIC FIBROSIS$3,562
M01 · FY2005 · RR
MULTICENTER INVESTIGATION OF GENETIC MODIFIER IN CF LUNG OR LIVER DISEASE STUDY$1,942
M01 · FY2005 · RR
BIIL 284 BS IN ADULT AND PEDIATRIC CYSTIC FIBROSIS PATIENTS$971
M01 · FY2005 · RR
Oral TheraCLEC to Treat Cystic Fibrosis$7,758
M01 · FY2004 · RR
Aztreonam for Inhalation in Subjects w/ Cystic Fibrosis$4,385
M01 · FY2004 · RR
BIIL 284 BS in Adult and Pediatric Cystic Fibrosis$1,687
M01 · FY2004 · RR
TRIAL OF IB-367 IN ADULT PATIENTS WITH CYSTIC FIBROSIS$0
M01 · FY2002 · RR
ORAL MULTIDOSE CPX IN ADULT PATIENTS W/ CYSTIC FIBROSIS$0
M01 · FY2002 · RR
ELASTASE IN BAL FLUID W TG-HAAT TREATED CYSTIC FIBROSIS$0
M01 · FY2002 · RR
TRIAL OF IB-367 IN ADULT PATIENTS WITH CYSTIC FIBROSIS$0
M01 · FY2001 · RR
ORAL MULTIDOSE CPX IN ADULT PATIENTS W/ CYSTIC FIBROSIS$0
M01 · FY2001 · RR
ELASTASE IN BAL FLUID W TG-HAAT TREATED CYSTIC FIBROSIS$0
M01 · FY2001 · RR
PHASE I TRIAL OF CPX IN ADULTS WITH MILD CYSTIC FIBROSIS$22,028
M01 · FY2000 · RR
ORAL MULTIDOSE CPX IN ADULT PATIENTS W/ CYSTIC FIBROSIS$22,028
M01 · FY2000 · RR
ALBUTEROL BY DRY POWDER INHALER &PRESSURIZED METERED DOSE VENTOLIN INHALER$22,028
M01 · FY2000 · RR
TRIAL OF IB-367 IN ADULT PATIENTS WITH CYSTIC FIBROSIS$0
M01 · FY2000 · RR
ELASTASE IN BAL FLUID W TG-HAAT TREATED CYSTIC FIBROSIS$0
M01 · FY2000 · RR